CellaVision AB
STO:CEVI
CellaVision AB
STO:CEVI
Price:
191.8
SEK
0.95%
Market Closed
Market Cap:
4.6B
SEK
Balance Sheet
Balance Sheet Decomposition
CellaVision AB
CellaVision AB
| Current Assets | 438.3m |
| Cash & Short-Term Investments | 182.3m |
| Receivables | 136.6m |
| Other Current Assets | 119.4m |
| Non-Current Assets | 605.6m |
| Long-Term Investments | 2.5m |
| PP&E | 112.3m |
| Intangibles | 490.8m |
Balance Sheet
CellaVision AB
CellaVision AB
Currency: SEK
Millions
Annual
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
107
|
132
|
155
|
169
|
102
|
102
|
130
|
108
|
122
|
149
|
|
| Cash |
107
|
132
|
155
|
169
|
102
|
102
|
130
|
108
|
122
|
149
|
|
| Total Receivables |
42
|
42
|
50
|
84
|
103
|
106
|
114
|
120
|
110
|
122
|
|
| Accounts Receivables |
35
|
33
|
43
|
76
|
89
|
71
|
90
|
98
|
98
|
103
|
|
| Other Receivables |
6
|
9
|
7
|
8
|
14
|
35
|
24
|
22
|
12
|
19
|
|
| Inventory |
25
|
36
|
29
|
34
|
55
|
84
|
115
|
143
|
126
|
125
|
|
| Other Current Assets |
4
|
5
|
6
|
7
|
5
|
6
|
5
|
7
|
8
|
7
|
|
| Total Current Assets |
177
|
216
|
239
|
295
|
265
|
298
|
365
|
377
|
366
|
403
|
|
| PP&E Net |
3
|
3
|
5
|
7
|
54
|
47
|
80
|
110
|
126
|
120
|
|
| PP&E Gross |
3
|
3
|
5
|
7
|
54
|
47
|
80
|
110
|
126
|
120
|
|
| Accumulated Depreciation |
3
|
4
|
5
|
7
|
30
|
44
|
59
|
72
|
91
|
111
|
|
| Intangible Assets |
29
|
35
|
54
|
68
|
185
|
189
|
244
|
275
|
309
|
360
|
|
| Goodwill |
0
|
0
|
0
|
0
|
115
|
112
|
114
|
124
|
124
|
128
|
|
| Long-Term Investments |
1
|
2
|
3
|
4
|
22
|
22
|
22
|
5
|
4
|
3
|
|
| Other Long-Term Assets |
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
115
|
112
|
114
|
124
|
124
|
128
|
|
| Total Assets |
220
N/A
|
256
+16%
|
301
+17%
|
373
+24%
|
642
+72%
|
668
+4%
|
825
+24%
|
892
+8%
|
929
+4%
|
1 013
+9%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
7
|
16
|
21
|
27
|
22
|
21
|
45
|
48
|
33
|
32
|
|
| Accrued Liabilities |
27
|
28
|
22
|
35
|
44
|
30
|
37
|
38
|
46
|
58
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
51
|
46
|
41
|
42
|
36
|
14
|
|
| Other Current Liabilities |
2
|
5
|
8
|
10
|
9
|
7
|
12
|
5
|
5
|
5
|
|
| Total Current Liabilities |
37
|
49
|
51
|
72
|
126
|
104
|
135
|
133
|
119
|
109
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
123
|
87
|
96
|
60
|
29
|
13
|
|
| Deferred Income Tax |
0
|
1
|
6
|
8
|
39
|
43
|
48
|
53
|
60
|
69
|
|
| Other Liabilities |
0
|
0
|
2
|
2
|
6
|
4
|
4
|
4
|
5
|
6
|
|
| Total Liabilities |
37
N/A
|
50
+36%
|
60
+19%
|
82
+38%
|
293
+256%
|
238
-19%
|
282
+18%
|
250
-11%
|
212
-15%
|
197
-7%
|
|
| Equity | |||||||||||
| Common Stock |
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
|
| Retained Earnings |
169
|
192
|
224
|
277
|
340
|
429
|
537
|
608
|
685
|
772
|
|
| Additional Paid In Capital |
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
11
|
|
| Other Equity |
0
|
0
|
2
|
1
|
6
|
14
|
8
|
19
|
17
|
29
|
|
| Total Equity |
184
N/A
|
206
+12%
|
241
+17%
|
290
+21%
|
348
+20%
|
430
+23%
|
543
+26%
|
642
+18%
|
716
+12%
|
816
+14%
|
|
| Total Liabilities & Equity |
220
N/A
|
256
+16%
|
301
+17%
|
373
+24%
|
642
+72%
|
668
+4%
|
825
+24%
|
892
+8%
|
929
+4%
|
1 013
+9%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
